GBP1 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P32455 |
---|---|
Clone Names | 100318065 |
Peptide ID | 100318065 |
Gene ID | 2633 |
---|---|
Other Names | Interferon-induced guanylate-binding protein 1, GTP-binding protein 1, GBP-1, HuGBP-1, Guanine nucleotide-binding protein 1, GBP1 |
Format | Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | GBP1 |
---|---|
Function | Hydrolyzes GTP to GMP in 2 consecutive cleavage reactions. Exhibits antiviral activity against influenza virus. Promote oxidative killing and deliver antimicrobial peptides to autophagolysosomes, providing broad host protection against different pathogen classes. |
Cellular Location | Cytoplasm. Golgi apparatus membrane; Lipid-anchor; Cytoplasmic side. Cell membrane. Secreted. Note=Secreted from endothelial cells in the cerebrospinal fluid, upon bacterial challenge and independently of IFNG induction. Golgi membrane localization requires isoprenylation and the presence of another IFNG-induced factor |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abgent.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Guanylate binding protein expression is induced byinterferon. Guanylate binding proteins are characterized by theirability to specifically bind guanine nucleotides (GMP, GDP, andGTP) and are distinguished from the GTP-binding proteins by thepresence of 2 binding motifs rather than 3.
References
Vopel, T., et al. J. Mol. Biol. 400(1):63-70(2010)Mirpuri, J., et al. J. Immunol. 184(12):7186-7195(2010)Lipnik, K., et al. Mol. Med. 16 (5-6), 177-187 (2010) :Davila, S., et al. Genes Immun. 11(3):232-238(2010)O'Doherty, C., et al. Pharmacogenomics 10(7):1177-1186(2009)

If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.